Security key
90466Y103
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)
CUSIP: 90466Y103
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 13,030,671
- Total 13F value
- $11,307,131
- Share change
- -1,162,143
- SEC-reported price per share
- $0.87
- Number of holders
- 16
- Value change
- -$1,007,258
- Number of buys
- 7
- Number of sells
- 6
- Shares outstanding
- 18,578,488
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
16
Top holders
10
UNCY full security history
Ownership snapshot
Full 13F holder table
Unicycive Therapeutics, Inc. SEC filings
Unicycive Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F
Highest disclosed value: $2,984,792
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $2.98M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value
Top 5
RA CAPITAL MANAGEMENT, L.P.
$2.98M
Nantahala Capital Management, LLC
$2.98M
Vivo Capital, LLC
$2.98M
BVF INC/IL
$2.94M
VANGUARD GROUP INC
$98.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
—
denominator unverified
|
$2,984,792
3,470,688 shares
|
— | 30 Sep 2023 |
| Nantahala Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$2,984,666
3,470,541 shares
|
— | 30 Sep 2023 |
| Vivo Capital, LLC |
13F
Company
|
—
denominator unverified
|
$2,984,331
3,470,152 shares
|
— | 30 Sep 2023 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$2,935,664
3,413,563 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$98,949
115,057 shares
|
— | 30 Sep 2023 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
denominator unverified
|
$80,180
93,233 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
13,030,671
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
16
Q4 2023 holders
16
Holder diff
0
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|